Pages

Monday, March 11, 2013

Feds letting Arkansas privatize Medicaid expansion; idea could spread like wildfire, as in Florida, but cost questions remain

Arkansas has turned heads nationally with its preliminary plan to expand Medicaid using the private insurance market, showing that the Obama administration is willing to give states more flexibility than expected in expanding the program.

Health and Human Services Secretary Kathleen Sebelius has agreed to a proposal by Arkansas Gov. Mike Beebe to reject the Medicaid expansion but use federal money to buy private health insurance for the 200,000 people who would have been covered under ordinary expansion, reports Sandhya Somashekhar of The Washington Post.

States that have come down on either sides of the Medicaid-expansion issue may reconsider their decision in light of the Arkansas proposal, said Sara Rosenbaum, a health law professor at George Washington University. "If Arkansas is allowed to do this, I expect it to spread like wildfire," Rosenbaum told the Post.

The first place could be Florida, where a state Senate committee rejected Republican Gov. Rick Scott's expansion plan and proposed a privatization plan like that in Arkansas. Last week, a House committee voted to reject any expansion of the program. Scott "made it clear he was not going to lobby the Legislature on Medicaid," preferring to emphasize other issues, The New York Times' Lizette Alvarez reports. For coverage from the Tampa Bay Times and The Miami Herald, click here.

Could the wildfire spread all the way up to Kentucky?

Gov. Steve Beshear has said he wants to expand Medicaid in Kentucky if the state can afford it, but many Republican lawmakers oppose the idea, saying it would not be fiscally responsible. On the national level, 26 states and the District of Columbia have expressed a desire to expand Medicaid, 17 have said they reject it and seven are undecided, according to the nonpartisan Kaiser Family Foundation.

A more flexibile arrangement could be a game changer because it makes expansion more appealing, especially for states where expanding Medicaid has been politically unpopular and polarizing. in Arkansas, which has a Democratic governor and a Republicna legislature, officials say that from an ideological standpoint, using private insurance appeals to lawmakers from both parties, reports Somashekhar. She reports that even Democratic-led states might prefer this arrangement because it gets rid of some bureaucratic hurdles.

However, there are questions about cost. The Congressional Budget Office estimates that private insurance plans cost $3,000 more per person than Medicaid, reports Somashekhar. On the other hand, Arkansas officials say the move could ultimately save money in administrative charges along with other cost-control measures.

Although the Arkansas proposal is not concrete, it provides proof that the Department for Health and Human Services encourages innovative, state-based approaches to promote expansion. Many states may develop a new route best suited to their specific needs, without having to leave federal money on the table. (Read more)
Arkansas has turned heads nationally with its preliminary plan to expand Medicaid using the private insurance market, showing that the Obama administration is willing to give states more flexibility than expected in expanding the program.

Health and Human Services Secretary Kathleen Sebelius has agreed to a proposal by Arkansas Gov. Mike Beebe to reject the Medicaid expansion but use federal money to buy private health insurance for the 200,000 people who would have been covered under ordinary expansion, reports Sandhya Somashekhar of The Washington Post.

States that have come down on either sides of the Medicaid-expansion issue may reconsider their decision in light of the Arkansas proposal, said Sara Rosenbaum, a health law professor at George Washington University. "If Arkansas is allowed to do this, I expect it to spread like wildfire," Rosenbaum told the Post.

The first place could be Florida, where a state Senate committee rejected Republican Gov. Rick Scott's expansion plan and proposed a privatization plan like that in Arkansas. Last week, a House committee voted to reject any expansion of the program. Scott "made it clear he was not going to lobby the Legislature on Medicaid," preferring to emphasize other issues, The New York Times' Lizette Alvarez reports. For coverage from the Tampa Bay Times and The Miami Herald, click here.

Could the wildfire spread all the way up to Kentucky?

Gov. Steve Beshear has said he wants to expand Medicaid in Kentucky if the state can afford it, but many Republican lawmakers oppose the idea, saying it would not be fiscally responsible. On the national level, 26 states and the District of Columbia have expressed a desire to expand Medicaid, 17 have said they reject it and seven are undecided, according to the nonpartisan Kaiser Family Foundation.

A more flexibile arrangement could be a game changer because it makes expansion more appealing, especially for states where expanding Medicaid has been politically unpopular and polarizing. in Arkansas, which has a Democratic governor and a Republicna legislature, officials say that from an ideological standpoint, using private insurance appeals to lawmakers from both parties, reports Somashekhar. She reports that even Democratic-led states might prefer this arrangement because it gets rid of some bureaucratic hurdles.

However, there are questions about cost. The Congressional Budget Office estimates that private insurance plans cost $3,000 more per person than Medicaid, reports Somashekhar. On the other hand, Arkansas officials say the move could ultimately save money in administrative charges along with other cost-control measures.

Although the Arkansas proposal is not concrete, it provides proof that the Department for Health and Human Services encourages innovative, state-based approaches to promote expansion. Many states may develop a new route best suited to their specific needs, without having to leave federal money on the table. (Read more)
Read More


Deadly, recalled pills still circulating in Pennyrile Region

A pain reliever that has been recalled and declared dangerous by the Federal Drug Administration is still circulating around southern Kentucky.

The drug marketed under the name Reumofan Plus is being distributed in Elkton and the broader Pennyrile Region, despite being recalled, and a local doctor's office says patients on the drug have had dangerous side effects, reports Nick Tabor of the Kentucky New Era.

Dr. Keith Toms of Generations Primary Care told Tabor three of his patients have taken the drug and had bad side effects. One patient had dangerous elevations of liver enzymes, and two diabetic patients had dangerous spikes in blood sugar.

The Food and Drug Administration has received reports of deaths, strokes, severe internal bleeding, dizziness, insomnia, high blood sugar and other problems associated with the drug since June. The manufacturer, operating under the names Reumofan Plus USA, LLC and Reumofan USA, LLC, announced a voluntary product recall last month, reports Tabor.

According to the FDA, undeclared ingredients in the drug, which is used as a treatment for muscle pain, arthritis, osteoporosis, bone cancer and other conditions, could result in serious illness. Tabor reports a FDA laboratory analysis of Reumofan Plus found that it contains diclofenac sodium, a non-steroidal anti-inflammatory drug, and methocarbamol, a muscle relaxant.

Tabor reports the FDA has issued an alert telling consumers to stop taking the drug immediately and consult a health-care professional. The agency also said it may follow up on the Reumofan recall with warning letters, seizure, injunction requests or criminal charges. (Read more)
A pain reliever that has been recalled and declared dangerous by the Federal Drug Administration is still circulating around southern Kentucky.

The drug marketed under the name Reumofan Plus is being distributed in Elkton and the broader Pennyrile Region, despite being recalled, and a local doctor's office says patients on the drug have had dangerous side effects, reports Nick Tabor of the Kentucky New Era.

Dr. Keith Toms of Generations Primary Care told Tabor three of his patients have taken the drug and had bad side effects. One patient had dangerous elevations of liver enzymes, and two diabetic patients had dangerous spikes in blood sugar.

The Food and Drug Administration has received reports of deaths, strokes, severe internal bleeding, dizziness, insomnia, high blood sugar and other problems associated with the drug since June. The manufacturer, operating under the names Reumofan Plus USA, LLC and Reumofan USA, LLC, announced a voluntary product recall last month, reports Tabor.

According to the FDA, undeclared ingredients in the drug, which is used as a treatment for muscle pain, arthritis, osteoporosis, bone cancer and other conditions, could result in serious illness. Tabor reports a FDA laboratory analysis of Reumofan Plus found that it contains diclofenac sodium, a non-steroidal anti-inflammatory drug, and methocarbamol, a muscle relaxant.

Tabor reports the FDA has issued an alert telling consumers to stop taking the drug immediately and consult a health-care professional. The agency also said it may follow up on the Reumofan recall with warning letters, seizure, injunction requests or criminal charges. (Read more)
Read More


Survey finds employees pay greater share of health costs, and most large employers penalize them for using tobacco

As large employers respond to changes influenced by health care reform and rising costs of care, employees are paying a greater portion of their health-care costs. That trend that is likely to continue over the next few years, says a new report on employer-based health plans.

Although employers cover most costs of work-based plans, employees contribute 42 percent more for health coverage than they did five years ago, while employers paid 32 percent more, according to the study from the benefits consultant Towers Watson and the National Business Group on Health. Overall, costs went up 34.4 percent.

When employers were asked if they thought health plans would change by 2018, which is the year the excise tax on high-cost plans takes effect, 92 percent said plans would be different, and nearly half said they expect a significant or transformative change. Such change will increase both accountability and engagement for employees.
% of large employers saying they were "very confident" they would offer health benefits in 2022
Nearly two-thirds of employers surveyed offer employees financial rewards to encourage participation in health programs, according to the report, which said tying employee contributions to successful completion of specific tasks, such as health assessments and screenings, remains the most popular contribution strategy. Growth in the use of penalties to engage employees in health-program participation has slowed over the last two years, but the use of surcharges for tobacco use continues to grow. By 2014, 62 percent of surveyed companies are expected to apply tobacco-use surcharges.

"While U.S. employers remain committed to health care benefits for active employees over the next five years," the report says, "they are redifining their financial commitment in the short run and are more reluctant to commit to coverage for employees over a longer period."

The 18th annual Towers Watson/National Business Group on Health Employer Survey on Purchasing Value in Health Care tracks employers' strategies and practices. It was completed by 583 employers,between November 2012 and January 2013. The report says it identifies the actions of the best performing companies as well as current trends in health-care benefit programs of U.S. employers with at least 1,000 employees. Survey respondents collectively employ 11.3 million full-time employees and have 8.5 million employees enrolled in their health care programs. Download a report PDF by clicking here.
As large employers respond to changes influenced by health care reform and rising costs of care, employees are paying a greater portion of their health-care costs. That trend that is likely to continue over the next few years, says a new report on employer-based health plans.

Although employers cover most costs of work-based plans, employees contribute 42 percent more for health coverage than they did five years ago, while employers paid 32 percent more, according to the study from the benefits consultant Towers Watson and the National Business Group on Health. Overall, costs went up 34.4 percent.

When employers were asked if they thought health plans would change by 2018, which is the year the excise tax on high-cost plans takes effect, 92 percent said plans would be different, and nearly half said they expect a significant or transformative change. Such change will increase both accountability and engagement for employees.
% of large employers saying they were "very confident" they would offer health benefits in 2022
Nearly two-thirds of employers surveyed offer employees financial rewards to encourage participation in health programs, according to the report, which said tying employee contributions to successful completion of specific tasks, such as health assessments and screenings, remains the most popular contribution strategy. Growth in the use of penalties to engage employees in health-program participation has slowed over the last two years, but the use of surcharges for tobacco use continues to grow. By 2014, 62 percent of surveyed companies are expected to apply tobacco-use surcharges.

"While U.S. employers remain committed to health care benefits for active employees over the next five years," the report says, "they are redifining their financial commitment in the short run and are more reluctant to commit to coverage for employees over a longer period."

The 18th annual Towers Watson/National Business Group on Health Employer Survey on Purchasing Value in Health Care tracks employers' strategies and practices. It was completed by 583 employers,between November 2012 and January 2013. The report says it identifies the actions of the best performing companies as well as current trends in health-care benefit programs of U.S. employers with at least 1,000 employees. Survey respondents collectively employ 11.3 million full-time employees and have 8.5 million employees enrolled in their health care programs. Download a report PDF by clicking here.
Read More


Louisville dental school to mark Women's History Month with women's art and oral-health fair and reception

The University of Louisville School of Dentistry will kick off its Women's History Month celebration March 18 with "Chew Art," an all-women's art and oral-health fair and reception.

In an effort to better engage with the community on issues related to oral health, increase oral health literacy and celebrate Women's History Month, the fair will focus on specific oral health care needs of women. The school will provide oral health information, and in some cases, limited screenings for women who live with diabetes, hypertension, who are pregnant or undergoing various treatments for cancer.

But the school says this event will not be like an ordinary trip to the dentist or health fair; it will be much more exciting! It is teaming up with Kristen Hughes, Arts in Healing manager at the Kentucky Center for the Performing Arts, to employ an innovative Arts in Health Care approach. Unlike the normal clinical environment, original works of art, created by a group of local female artists, will be on display at the fair.

The "Chew Art" event will take place Monday, March 18, from 5 to 7 p.m. on the second floor of the newly renovated dental building at 501 S. Preston St. and will feature tapas, wine, sangria and live music in addition to the art displays.  To RSVP, email Deborah Wade at D0wade01@louisville.edu.
The University of Louisville School of Dentistry will kick off its Women's History Month celebration March 18 with "Chew Art," an all-women's art and oral-health fair and reception.

In an effort to better engage with the community on issues related to oral health, increase oral health literacy and celebrate Women's History Month, the fair will focus on specific oral health care needs of women. The school will provide oral health information, and in some cases, limited screenings for women who live with diabetes, hypertension, who are pregnant or undergoing various treatments for cancer.

But the school says this event will not be like an ordinary trip to the dentist or health fair; it will be much more exciting! It is teaming up with Kristen Hughes, Arts in Healing manager at the Kentucky Center for the Performing Arts, to employ an innovative Arts in Health Care approach. Unlike the normal clinical environment, original works of art, created by a group of local female artists, will be on display at the fair.

The "Chew Art" event will take place Monday, March 18, from 5 to 7 p.m. on the second floor of the newly renovated dental building at 501 S. Preston St. and will feature tapas, wine, sangria and live music in addition to the art displays.  To RSVP, email Deborah Wade at D0wade01@louisville.edu.
Read More


Geographic variation in FeLV and FIV in the U.S.

Chhetri B, Berke O, Pearl D and Bienzle D. Comparison of the geographical distribution of feline immunodeficiency virus and feline leukemia virus infections in the United States of America (2000--2011). BMC Veterinary Research. 2013; 9: 2. [free, full text article] 
 
Feline leukemia virus (FeLV) and feline immunodeficiency virus (FIV) share many risk factors for infection in cats. However, infection rates are thought to vary depending on location. Geographical distribution of each may vary. These investigators looked at the geographical distribution of both viruses in the U.S. Testing results for over 17,000 (FIV) and 30,000 (FeLV) cats were analyzed for the 48 contiguous states. The results indicate that risk factors may vary in different geographic locales. There is a higher prevalence of FIV in the southeastern U.S. compared with FeLV. In contrast, FeLV occurred at a higher rate in the western U.S. compared with FIV. This may be due to geographic variations in virus strains, vaccination rates, or as yet unknown geographic risk factors for each virus. While more research is needed to understand the specific risk factors responsible, this knowledge could influence recommendations for testing, management, and prevention. [MK]

See also:
Levy J, Crawford C, Hartmann K, et al. 2008 American Association of Feline Practitioners' feline retrovirus management guidelines. J Feline Med Surg. 2008; 10: 300-16. [free, full text]

Little S, Bienzle D, Carioto L, Chisholm H, O'Brien E and Scherk M. Feline leukemia virus and feline immunodeficiency virus in Canada: recommendations for testing and management. Can Vet J. 2011; 52: 849-55. [free, full text] 

More on cat health:
Winn Feline Foundation Library
Find us on Facebook
Follow us on Twitter
Join us on Google+
Chhetri B, Berke O, Pearl D and Bienzle D. Comparison of the geographical distribution of feline immunodeficiency virus and feline leukemia virus infections in the United States of America (2000--2011). BMC Veterinary Research. 2013; 9: 2. [free, full text article] 
 
Feline leukemia virus (FeLV) and feline immunodeficiency virus (FIV) share many risk factors for infection in cats. However, infection rates are thought to vary depending on location. Geographical distribution of each may vary. These investigators looked at the geographical distribution of both viruses in the U.S. Testing results for over 17,000 (FIV) and 30,000 (FeLV) cats were analyzed for the 48 contiguous states. The results indicate that risk factors may vary in different geographic locales. There is a higher prevalence of FIV in the southeastern U.S. compared with FeLV. In contrast, FeLV occurred at a higher rate in the western U.S. compared with FIV. This may be due to geographic variations in virus strains, vaccination rates, or as yet unknown geographic risk factors for each virus. While more research is needed to understand the specific risk factors responsible, this knowledge could influence recommendations for testing, management, and prevention. [MK]

See also:
Levy J, Crawford C, Hartmann K, et al. 2008 American Association of Feline Practitioners' feline retrovirus management guidelines. J Feline Med Surg. 2008; 10: 300-16. [free, full text]

Little S, Bienzle D, Carioto L, Chisholm H, O'Brien E and Scherk M. Feline leukemia virus and feline immunodeficiency virus in Canada: recommendations for testing and management. Can Vet J. 2011; 52: 849-55. [free, full text] 

More on cat health:
Winn Feline Foundation Library
Find us on Facebook
Follow us on Twitter
Join us on Google+
Read More


Sunday, March 10, 2013

Probiotics are not only powerful gut-healers - they improve bone density, study shows


A doctor of traditional Chinese medicine (TCM) once told this author that "disease begins in the gut." Ayurvedic medicine also has a similar premise. Bad or sub-optimal digestion leads to all sorts of disease. That includes disease beyond the gastrointestinal (GI) tract.

Dr. Natasha Campbell-McBride and others in Western medicine have taken this premise beyond physical ailments into the mind-body relationship with GAPS, or Gut and Psychology Syndrome, by treating mental disorders from ADD to Autism.

Their success has come from altering the diet to allow the gut to heal and good bacteria in the intestinal flora to thrive.

So there's more to the good bacteria in the gut than most think. Even more than digestion, as important as that is. These supportive bacteria in the gut also signal different parts of the immune system in other areas of the body. It's estimated that up to 80 percent of the immune system is involved with the gut's good bacteria.



The word probiotic means pro-life. These friendly, life-supporting critters are killed off by antibiotics. They're absent in dead foods that comprise the standard American diet (SAD), and are genetically disturbed by GMO transfer genes and viruses.


Yes, GMOs destroy the immune system through the gut and more. And when is the last time you were advised to take probiotic supplements when you were prescribed an antibiotic? That's just not part of the medical monopoly's protocol, despite ongoing research that keeps finding different important aspects of probiotic bacteria.

Mainstream research into probiotic benefits

The study "Probiotic use decreases intestinal inflammation and increases bone density in healthy male but not female mice" was recorded in the Journal of Cellular Physiology late January 2013.

The University of Michigan State researchers fed mice Lactobacillus reuteri for a period of four weeks. Lacobacillus reuteri has been determined from other research to be effective at reducing gut inflammation and effective for treating inflammatory bowel disease.

The fact that inflammation in the gut has been associated with osteoporosis led the researchers to explore what improves gut inflammation as a possible application for bone disease.

The researchers discovered that male mice had improved bone density after ingesting Lacobacillus reuteri, but oddly; female mice did not demonstrate improved bone density. The tacit implication is females may need a variation of the probiotic used.

More research was called upon after discovering this link of probiotics and bone density to determine which probiotics would be the most appropriate for each person to prescribe as a medication for osteoporosis.

Other studies have discovered the importance of probiotics for improving health in different areas.

For example, in 2011 The Cochrane Library reviewed several studies and determined that probiotics such as lactic acid bacteria and bifidobacteria could help resist or resolve upper respiratory tract infection (URTI) from colds, flus, and even pneumonia.

Several studies have confirmed the efficacy of probiotics for prolonged infectious diarrhea among children and irritable bowel syndrome (IBS).

Obviously, the left hand doesn't know what the right hand does as more and more dead food, GMOs, and antibiotics are pushed by the food and medical industry.

You would be wise to stay away from the dead and genetically engineered foods and avoid synthetic antibiotics. At least dose heavily with probiotic supplements if forced into antibiotics.

Some natural antibiotics aren't so selective with what mini-critters they kill too. You may need probiotic supplements more than once in a while.

But for probiotic maintenance, search for raw dairy, create fermented foods, and consume prebiotic superfoods that encourage probiotic bacteria to flourish.

We all need to get by with a lot of help from our little friends.




About Dr Kevin Lau


Dr Kevin Lau is a Singapore chiropractor and the founder of Health In Your Hands, a series of tools for Scoliosis prevention and treatment. The set includes his book Your Plan for Natural Scoliosis Prevention and Treatment, a companion Scoliosis Exercises for Prevention and Correction DVD and the innovative new iPhone application ScolioTrack. Dr Kevin Lau is a graduate in Doctor of Chiropractic from RMIT University in Melbourne Australia and Masters in Holistic Nutrition. He is a member of International Society On Scoliosis Orthopaedic and Rehabilitation Treatment (SOSORT), the leading international society on conservative treatment of spinal deformities. In 2006 I was awarded the "Best Health-care Provider Awards" by the largest Newspaper publication in Singapore on October 18 2006 as well as being interviewed on Primetime Channel News Asia as well as other TV and Radio. For more information on Dr Kevin Lau, watch his interviews or get a free sneak peek of his book, go to:

Website - http://www.hiyh.info.
ScolioTrack Website - http://www.ScolioTrack.com.
Facebook - https://www.facebook.com/HealthInYourHands.
Youtube - http://www.youtube.com/user/DrKevinLau.
Twitter - http://www.Twitter.com/DrKevinLau.

A doctor of traditional Chinese medicine (TCM) once told this author that "disease begins in the gut." Ayurvedic medicine also has a similar premise. Bad or sub-optimal digestion leads to all sorts of disease. That includes disease beyond the gastrointestinal (GI) tract.

Dr. Natasha Campbell-McBride and others in Western medicine have taken this premise beyond physical ailments into the mind-body relationship with GAPS, or Gut and Psychology Syndrome, by treating mental disorders from ADD to Autism.

Their success has come from altering the diet to allow the gut to heal and good bacteria in the intestinal flora to thrive.

So there's more to the good bacteria in the gut than most think. Even more than digestion, as important as that is. These supportive bacteria in the gut also signal different parts of the immune system in other areas of the body. It's estimated that up to 80 percent of the immune system is involved with the gut's good bacteria.



The word probiotic means pro-life. These friendly, life-supporting critters are killed off by antibiotics. They're absent in dead foods that comprise the standard American diet (SAD), and are genetically disturbed by GMO transfer genes and viruses.


Yes, GMOs destroy the immune system through the gut and more. And when is the last time you were advised to take probiotic supplements when you were prescribed an antibiotic? That's just not part of the medical monopoly's protocol, despite ongoing research that keeps finding different important aspects of probiotic bacteria.

Mainstream research into probiotic benefits

The study "Probiotic use decreases intestinal inflammation and increases bone density in healthy male but not female mice" was recorded in the Journal of Cellular Physiology late January 2013.

The University of Michigan State researchers fed mice Lactobacillus reuteri for a period of four weeks. Lacobacillus reuteri has been determined from other research to be effective at reducing gut inflammation and effective for treating inflammatory bowel disease.

The fact that inflammation in the gut has been associated with osteoporosis led the researchers to explore what improves gut inflammation as a possible application for bone disease.

The researchers discovered that male mice had improved bone density after ingesting Lacobacillus reuteri, but oddly; female mice did not demonstrate improved bone density. The tacit implication is females may need a variation of the probiotic used.

More research was called upon after discovering this link of probiotics and bone density to determine which probiotics would be the most appropriate for each person to prescribe as a medication for osteoporosis.

Other studies have discovered the importance of probiotics for improving health in different areas.

For example, in 2011 The Cochrane Library reviewed several studies and determined that probiotics such as lactic acid bacteria and bifidobacteria could help resist or resolve upper respiratory tract infection (URTI) from colds, flus, and even pneumonia.

Several studies have confirmed the efficacy of probiotics for prolonged infectious diarrhea among children and irritable bowel syndrome (IBS).

Obviously, the left hand doesn't know what the right hand does as more and more dead food, GMOs, and antibiotics are pushed by the food and medical industry.

You would be wise to stay away from the dead and genetically engineered foods and avoid synthetic antibiotics. At least dose heavily with probiotic supplements if forced into antibiotics.

Some natural antibiotics aren't so selective with what mini-critters they kill too. You may need probiotic supplements more than once in a while.

But for probiotic maintenance, search for raw dairy, create fermented foods, and consume prebiotic superfoods that encourage probiotic bacteria to flourish.

We all need to get by with a lot of help from our little friends.




About Dr Kevin Lau


Dr Kevin Lau is a Singapore chiropractor and the founder of Health In Your Hands, a series of tools for Scoliosis prevention and treatment. The set includes his book Your Plan for Natural Scoliosis Prevention and Treatment, a companion Scoliosis Exercises for Prevention and Correction DVD and the innovative new iPhone application ScolioTrack. Dr Kevin Lau is a graduate in Doctor of Chiropractic from RMIT University in Melbourne Australia and Masters in Holistic Nutrition. He is a member of International Society On Scoliosis Orthopaedic and Rehabilitation Treatment (SOSORT), the leading international society on conservative treatment of spinal deformities. In 2006 I was awarded the "Best Health-care Provider Awards" by the largest Newspaper publication in Singapore on October 18 2006 as well as being interviewed on Primetime Channel News Asia as well as other TV and Radio. For more information on Dr Kevin Lau, watch his interviews or get a free sneak peek of his book, go to:

Website - http://www.hiyh.info.
ScolioTrack Website - http://www.ScolioTrack.com.
Facebook - https://www.facebook.com/HealthInYourHands.
Youtube - http://www.youtube.com/user/DrKevinLau.
Twitter - http://www.Twitter.com/DrKevinLau.
Read More


Thursday, March 7, 2013

Nightmare, drug-resistant superbugs, including one that kills half the people who get it, are a big threat

"Nightmare bacteria" leading to deadly infections that are difficult and sometimes impossible to treat are on the rise in American hospitals, and threaten to spread to otherwise healthy people outside of medical facilities, according to a federal Centers for Disease Control Vital Signs report published Tuesday.

These superbugs, carbapenem-resistant Enterobacteriaceae, or CRE, have become resistant to nearly all the antibiotics available today, including drugs of last resort. According to the report, CRE infections are caused by a family of germs that are a normal part of a person's healthy digestive system, but can cause infections when they get into the bladder, blood or other areas where they don't belong.

The report says almost all CRE infections are found in patients receiving serious medical care, and they kill up to half of patients who get bloodstream infections from them. In addition to spreading among people, CREs easily spread their antibiotic resistance to other kinds of germs, making those potentially untreatable as well.

Only 10 years ago, such resistance was hardly ever seen in this group of germs. Although these superbugs are uncommon, their prevalence has quadrupled in the past decade in medical facilities in 42 states, the CDC says.

The report calls for immediate action to stop the spread of these deadly infection; it is a critical time for U.S. doctors, nurses lab staff, medical facility leaders, health departments, states, policymakers and patients to help fight the spread through coordinated and consistent efforts.

The report asks patients to do three things: Tell your doctor if you have been hospitalized in another facility or country, take antibiotics only as prescribed, and insist that everyone wash their hands before touching you. For more details, click here for the Vital Signs report.
"Nightmare bacteria" leading to deadly infections that are difficult and sometimes impossible to treat are on the rise in American hospitals, and threaten to spread to otherwise healthy people outside of medical facilities, according to a federal Centers for Disease Control Vital Signs report published Tuesday.

These superbugs, carbapenem-resistant Enterobacteriaceae, or CRE, have become resistant to nearly all the antibiotics available today, including drugs of last resort. According to the report, CRE infections are caused by a family of germs that are a normal part of a person's healthy digestive system, but can cause infections when they get into the bladder, blood or other areas where they don't belong.

The report says almost all CRE infections are found in patients receiving serious medical care, and they kill up to half of patients who get bloodstream infections from them. In addition to spreading among people, CREs easily spread their antibiotic resistance to other kinds of germs, making those potentially untreatable as well.

Only 10 years ago, such resistance was hardly ever seen in this group of germs. Although these superbugs are uncommon, their prevalence has quadrupled in the past decade in medical facilities in 42 states, the CDC says.

The report calls for immediate action to stop the spread of these deadly infection; it is a critical time for U.S. doctors, nurses lab staff, medical facility leaders, health departments, states, policymakers and patients to help fight the spread through coordinated and consistent efforts.

The report asks patients to do three things: Tell your doctor if you have been hospitalized in another facility or country, take antibiotics only as prescribed, and insist that everyone wash their hands before touching you. For more details, click here for the Vital Signs report.
Read More